Eli Lilly

News

Regeneron's antibody cocktail cuts COVID hospitalisation in ...

Regeneron has posted findings from a large trial of its COVID-19 antibody cocktail showing the therapy reduced risk of hospitalisation or death by 70%.

News

Red spine and vertebral column of a human skeleton

FDA worried about Pfizer/Lilly pain drug safety ahead of key...

After a long and troubled development the fate of Pfizer/Lilly’s tanezumab painkiller injection is in the balance ahead of a key meeting of advisers later this week.

News

Lilly's mirikuzumab hits target in phase 3 ulcerative coliti...

A phase 3 trial of Lilly’s inflammatory diseases challenger mirikizumab in ulcerative colitis has met its target – potentially adding further competition to a crowded market.

News

New era of genomic medicine begins as UK approves Lilly's Re...

The UK regulator has authorised Eli Lilly’s targeted cancer drug Retsevmo for tumours with RET fusion positive lung cancers and thyroid cancers, which the company said could herald a new er

News

Closeup of X-ray photography of human brain

AI platform says Olumiant could be repurposed for Alzheimer’...

With so many novel drug candidates for Alzheimer’s disease failing in clinical development, researchers in the US have started using artificial intelligence (AI) to screen already-approved

News

Goofy lama pulling face. Funny llama animal sticking tongue out

ExeVir ready for clinic with variant-targeting llama antibod...

Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – and now it is ready to begin clinical development of a potential treatment

Regeneron's antibody cocktail cuts COVID hospitalisation in ...

FDA worried about Pfizer/Lilly pain drug safety ahead of key...

Lilly's mirikuzumab hits target in phase 3 ulcerative coliti...

New era of genomic medicine begins as UK approves Lilly's Re...

AI platform says Olumiant could be repurposed for Alzheimer’...

ExeVir ready for clinic with variant-targeting llama antibod...

AI for the planet, AI for life sciences – with Patrick Leung

How to meet your physicians where they are online

Eli Lilly

Editor's Picks